MMarketMath

MRSH

StalwartQuality: High (88/100)

Marsh McLennan · Financials · Insurance Brokers

$194.67

52w 156.60 – 211.28

20y monthly, adjusted

Mkt cap

$92.9B

P/E

21.4

P/FCF

17.8

FCF yield

5.6%

ROE

27.2%

Shldr yield

4.2%

div 1.9% + bb 2.3%

What today's price assumes

At $92.9B, the market is pricing in 6.1% annual free-cash-flow growth for the next decade (10% discount rate, 2.5% terminal growth). Over the last ten years, FCF actually grew 12.3% per year — expectations look undemanding relative to history.

Simple DCF per-share range: $160 · $295 · $368 (4% / base / optimistic growth). An estimate, not a target.

Adjust the assumptions yourself →

Historical multiple lens

At its own median P/OCF of 20.4× across 10 years, MRSH would trade near $226/share (25th–75th percentile: $185–$242); it trades at 17.6× today.

Assumes the historical multiple regime persists — re-ratings can be permanent.

Growth record

Compound annual growth rates from as-filed 10-K data, split-adjusted

Rev 3y

+9.2%

Rev 5y

+9.4%

Rev 10y

+8.3%

EPS 5y

+16.4%

EPS 10y

+10.7%

FCF 5y

+10.5%

FCF 10y

+12.3%

Fundamentals

Fiscal 2016–2025, from SEC filings

Revenue

2016: $13.2B
2017: $14.0B
2018: $14.9B
2019: $16.7B
2020: $17.2B
2021: $19.8B
2022: $20.7B
2023: $22.7B
2024: $24.5B
2025: $27.0B
$0$10.0B$20.0B
16
18
20
22
24

Net income

2016: $1.8B
2017: $1.5B
2018: $1.6B
2019: $1.7B
2020: $2.0B
2021: $3.1B
2022: $3.0B
2023: $3.8B
2024: $4.1B
2025: $4.2B
$0$2.0B$4.0B
16
18
20
22
24

Free cash flow

2016: $1.8B
2017: $1.6B
2018: $2.1B
2019: $1.9B
2020: $3.0B
2021: $3.1B
2022: $3.0B
2023: $3.8B
2024: $4.0B
2025: $5.0B
$0$2.0B$4.0B
16
18
20
22
24

Diluted shares (lower is better)

2016: 524.0M
2017: 519.0M
2018: 511.0M
2019: 511.0M
2020: 512.0M
2021: 513.0M
2022: 505.0M
2023: 499.0M
2024: 496.0M
2025: 494.0M
0200.0M400.0M
16
18
20
22
24

Margins

10%13%15%18%1618202224
Net marginFCF marginGross margin

Capital returned (dividends + buybacks)

2016: $1.5B
2017: $1.6B
2018: $1.5B
2019: $1.4B
2020: $943.0M
2021: $2.2B
2022: $3.1B
2023: $2.4B
2024: $2.4B
2025: $3.7B
$0$1.0B$2.0B$3.0B
16
18
20
22
24

Cash vs long-term debt

$0$10.0B$20.0B1618202224
CashLT debt

Quarterly

Discrete quarters from 10-Q filings; Q4 derived as fiscal year minus Q1–Q3. OCF is unwound from the year-to-date figures 10-Qs report. Compare to the same quarter a year ago — most businesses are seasonal.

Revenue by quarter

Q2'23: $5.9B
Q3'23: $5.4B
Q4'23: $5.6B
Q1'24: $6.5B
Q2'24: $6.2B
Q3'24: $5.7B
Q4'24: $6.1B
Q1'25: $7.1B
Q2'25: $7.0B
Q3'25: $6.4B
Q4'25: $6.6B
Q1'26: $7.6B
Q2'26: $7.4B
$0$2.0B$4.0B$6.0B
23
24
24
25
26

Net income by quarter

Q2'23: $1.0B
Q3'23: $730.0M
Q4'23: $756.0M
Q1'24: $1.4B
Q2'24: $1.1B
Q3'24: $747.0M
Q4'24: $788.0M
Q1'25: $1.4B
Q2'25: $1.2B
Q3'25: $747.0M
Q4'25: $821.0M
Q1'26: $1.1B
Q2'26: $1.3B
$0$500.0M$1.0B
23
24
24
25
26
QuarterRevenueYoYNet incomeYoYEPSOCF
Q2'26$7.4B+6.2%$1.3B+4.5%2.63$1.5B
Q1'26$7.6B+7.6%$1.1B−17.0%2.36−$688.0M
Q4'25 *$6.6B+8.7%$821.0M+4.2%1.68$2.2B
Q3'25$6.4B+11.5%$747.0M0.0%1.51$2.1B
Q2'25$7.0B+12.1%$1.2B+7.6%2.45$1.7B
Q1'25$7.1B+9.1%$1.4B−1.4%2.79−$622.0M
Q4'24 *$6.1B+9.2%$788.0M+4.2%1.58$2.0B
Q3'24$5.7B+5.9%$747.0M+2.3%1.51$1.9B
Q2'24$6.2B+5.9%$1.1B+8.7%2.27$1.2B
Q1'24$6.5B+9.3%$1.4B+13.4%2.82−$781.0M
Q4'23 *$5.6B+10.6%$756.0M+62.2%1.52$1.8B
Q3'23$5.4B+12.8%$730.0M+33.7%1.47$1.8B
Q2'23$5.9B+9.2%$1.0B+7.0%2.07$1.5B

Track record

Compound annual growth by period. For debt and share count, negative is the good direction.

Series3y5y10y15y
Revenue+9.2%+9.4%
Operating cash flow+15.2%+9.4%
Free cash flow+18.6%+10.5%
EPS (diluted)+11.8%+16.4%
Equity+12.5%+10.6%
LT debt+17.7%+11.2%
Diluted shares−0.7%−0.7%
Stock price+1.6%+6.0%+13.0%+15.5%

$100, 3 years ago

$105vs $176 in SPY

1.6% vs 20.7%/yr

$100, 5 years ago

$134vs $181 in SPY

6.0% vs 12.6%/yr

$100, 10 years ago

$341vs $412 in SPY

13.0% vs 15.2%/yr

$100, 15 years ago

$874vs $813 in SPY

15.5% vs 15.0%/yr

The $1 test — market value created per $1 of earnings retained (Buffett's hurdle: at least $1)

Last 5 years

$3.51

$40.3B created / $11.5B retained

Quality & capital discipline

Cash-based returns and how management deploys capital

Cash ROIC

15.7%

OCF ÷ (equity + debt)

OCF / EV yield

5.1%

MC vs 10× OCF

1.68

≤1 = priced under 10× OCF

Debt / FCF

3.7y

SBC / FCF

7.9%

Owner earnings

$4.6B

OCF − capex − SBC

OE yield

5.2%

Share count 5y

−0.7%

per year; negative = buybacks

Capital intensity

3.1%

net PP&E ÷ revenue

Sales efficiency

$-0.00

new PP&E per $1 new revenue, 5y

Growth engine (5y): reinvested 62.3% of operating cash flow at an incremental return of 14.7% — an organically fundable growth rate of about 9.2% per year (growth ≈ reinvestment rate × incremental ROIC).

Checklist

23 of 26 checks pass · 88%. Checks with structurally missing inputs are excluded.

Growth & Consistency

7/7

  • Revenue growth

    9.4% · 5y CAGR ≥ 5%

    pass
  • EPS growth

    16.4% · 5y CAGR ≥ 5%

    pass
  • FCF growth

    10.5% · 5y CAGR ≥ 5%

    pass
  • Revenue rises consistently

    9 of 9 · up in ≥ 7 of last 10 years

    pass
  • FCF consistently positive

    10 of 10 · positive in ≥ 8 of last 10 years

    pass
  • Profitable every year

    10 of 10 · net income > 0 in ≥ 8 of last 10

    pass
  • Cash flow keeps up with sales

    9.4% vs 9.4% · OCF CAGR ≥ 0.9× revenue CAGR

    pass

Profitability

6/6

  • Net margin

    15.4% · ≥ 8%

    pass
  • Operating margin

    23.1% · ≥ 10%

    pass
  • Gross margin stable or rising

    · no drop > 2 pts over 3y

    na
  • Return on equity

    27.2% · ≥ 12%

    pass
  • Cash ROIC

    15.7% · ≥ 12%

    pass
  • FCF margin

    18.5% · ≥ 5%

    pass
  • Earnings back their cash

    OCF $5.3B vs NI $4.2B · OCF ≥ net income (latest FY)

    pass

Balance Sheet

2/5

  • Debt payable from cash flow

    3.7y · LT debt ≤ 3× FCF

    fail
  • Cash cushion

    15% · cash ≥ 50% of LT debt

    fail
  • Leverage

    1.20 · LT debt ≤ 1.5× equity

    pass
  • Equity positive and compounding

    $15.3B · equity > 0 and grew over ~5y

    pass
  • Interest burden

    15% · interest ≤ 15% of operating income

    fail

Capital Allocation

4/4

  • Share count flat or shrinking

    -0.7% · ≤ +0.5%/yr over ~5y

    pass
  • Stock comp restrained

    8% · SBC ≤ 15% of FCF

    pass
  • Distributions funded by FCF

    74% · dividends + buybacks ≤ 100% of FCF

    pass
  • Repurchases are a habit

    9 of 10 · buybacks in ≥ 5 of last 10 years

    pass

Valuation Discipline

4/4

  • FCF yield

    5.6% · ≥ 3%

    pass
  • Earnings multiple

    21.4 · P/E ≤ 25

    pass
  • Price asks less than history delivered

    6.1% vs 12.3% · implied FCF growth ≤ historical FCF CAGR

    pass
  • Shareholder yield

    4.2% · dividends + buybacks ≥ 2% of market cap

    pass

Financial data

As filed in 10-Ks; per-share figures split-adjusted. $ in millions.

FYRevenueGross profitOp incomeNet incomeEPSOCFCapExFCFDividendsBuybacksSBCCashLT debtEquityShares
202526,9816,2234,1608.435,2922915,0011,6992,0123942,68718,32015,315494
202424,4585,8174,0608.184,3023163,9861,5139003682,39819,42813,535496
202322,7365,2823,7567.534,2584163,8421,2981,1503633,35811,84412,370499
202220,7204,2803,0506.043,4654702,9951,1381,9503671,44211,22710,749505
202119,8204,3123,1436.133,5164063,1101,0261,1593481,75210,93311,222513
202017,2243,0662,0163.943,3823483,03494302902,08910,7969,260512
201916,6522,6771,7423.412,3614211,9408904852521,15510,7417,943511
201814,9502,7611,6503.232,4283142,1148076751931,0665,5107,584511
201714,0242,6551,4922.871,8933021,5917409001491,2055,2257,442519
201613,2112,4311,7683.382,0072531,7546828001091,0264,4956,272524

Some concepts are structurally absent for certain industries (banks report no gross profit or capex). Missing ≠ zero.